| Dr Natasha K Balani, OD | |
|
3025 112th Ave Ne Ste 200, Bellevue, WA 98004-8002 | |
| (425) 451-2020 | |
| (425) 450-9696 |
| Full Name | Dr Natasha K Balani |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 3025 112th Ave Ne Ste 200, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821472499 | NPI | - | NPPES |
| 2023067 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 60570700 (Washington) | Primary |
| Provider Name | Sharpevision Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164788279 PECOS PAC ID: 5496917791 Enrollment ID: O20200226000148 |
News Archive
A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.
Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.
Leading HIV experts are alarmed that the government of The Gambia is encouraging citizens living with HIV to stop taking antiretroviral medications in order to try an unproven herbal remedy.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
University of Cincinnati (UC) researchers have found that an imbalance in the regulation of certain T cells-the cells in the body that fight off infection or attack the system in certain autoimmune diseases-may put certain people at a higher risk of having recurrent cases of Clostridium difficile, or C. Diff, infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natasha K Balani, OD 3025 112th Ave Ne Ste 200, Bellevue, WA 98004-8002 Ph: (425) 451-2020 | Dr Natasha K Balani, OD 3025 112th Ave Ne Ste 200, Bellevue, WA 98004-8002 Ph: (425) 451-2020 |
News Archive
A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.
Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.
Leading HIV experts are alarmed that the government of The Gambia is encouraging citizens living with HIV to stop taking antiretroviral medications in order to try an unproven herbal remedy.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
University of Cincinnati (UC) researchers have found that an imbalance in the regulation of certain T cells-the cells in the body that fight off infection or attack the system in certain autoimmune diseases-may put certain people at a higher risk of having recurrent cases of Clostridium difficile, or C. Diff, infection.
› Verified 5 days ago
Aimee Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Britlynn Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11120 Ne 33rd Pl, Bellevue, WA 98004 Phone: 206-426-2584 | |
Adl Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Thomas Xie, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1020 108th Ave Ne Apt 1401, Bellevue, WA 98004 Phone: 347-687-0712 | |
Dr. Grant Edward Lindberg, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Joanna Stedman Haws, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Dr. Theodore Stephen Kadet, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14030 Ne 24th St, Suite 101, Bellevue, WA 98007 Phone: 425-462-7800 Fax: 425-455-3019 |